Cytokine profile of bronchoalveolar lavage in patients with and without checkpoint inhibitor pneumonitis

Abstract Background Checkpoint inhibitor pneumonitis (CIP) that develops following immune checkpoint inhibitor (ICI) treatment can be difficult to distinguish from other common etiologies of lung inflammation in cancer patients. Here, we evaluate the bronchoalveolar lavage fluid (BAL) for potential...

Full description

Saved in:
Bibliographic Details
Main Authors: Michelle Ploch, Songzhu Zhao, Lai Wei, Joshua A. Englert, Sarah P. Cohen, Morgan A. Inks, Alexa S. Meara, Lynn A. Fussner, Dwight H. Owen, Kevin Ho
Format: Article
Language:English
Published: Springer 2025-01-01
Series:Cancer Immunology, Immunotherapy
Subjects:
Online Access:https://doi.org/10.1007/s00262-024-03902-3
Tags: Add Tag
No Tags, Be the first to tag this record!